Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 28.98% Profit

May 10, 2023
ELI LILLY AND COMPANY stock recently reached the price target forecast set by QuantWave, resulting in a profitable return of 28.98%. The forecast signal was given on February 3, 2023, with the stock price at 331.61 $. The predicted direction was long, and on May 10, 2023, the stock reached the target price of 427.69 $.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The market analysis indicates that various factors, such as strong financial performance, positive industry trends, and favorable market conditions, contributed to ELI LILLY AND COMPANY's stock growth.

QuantWave continues to provide valuable insights and forecasts for a wide range of stocks, offering opportunities for investors to capitalize on market movements. For those interested in enhancing their investment strategies, QuantSchool provides educational resources to guide users in generating consistent income through the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Hits Price Target Forecast with 18.31% Profit - QuantWave Achieves Success Once Again  ~2 min.

ELI LILLY AND COMPANY, one of the leading pharmaceutical companies, recently saw its stock price hitting the forecasted target with a profit of 18.31% as predicted by QuantWave on June 4, 2025....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 17.25% Profit: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently saw its stock hit the target forecast set by QuantWave, yielding a profit of 17.25%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 22.13% Profit  ~1 min.

ELI LILLY AND COMPANY stock successfully reached the forecasted target price of 639.46 $ on August 7, 2025, resulting in a profit of 22.13% for investors....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


WMTMay 16, 2024QuantWave Achieves 18.88% Profit Forecast on Walmart Inc. Stock  ~1 min.

On October 24, 2023, QuantWave, the automated forecasting platform, issued a long signal for Walmart Inc. stock with a price of $53.17. Today, on May 16, 2024, the target price of $63....


SBACApril 16, 2024QuantWave Achieves 9.31% Profit Target Forecast for SBA COMMUNICATIONS CORPORATION  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted a short direction for the stock of SBA COMMUNICATIONS CORPORATION on March 19, 2024, with a price target of 191....


NVDAMarch 22, 2024Profit Forecast Success for NVIDIA CORPORATION with 110.17% Gain  ~1 min.

QuantWave, the automated forecasting platform, has achieved a significant milestone with its price target forecast for NVIDIA CORPORATION....


MAJanuary 27, 2025MASTERCARD INCORPORATED Hits Price Target Forecast with 16.01% Profit  ~1 min.

On February 27, 2024, QuantWave issued a long signal for MASTERCARD INCORPORATED, with the stock trading at 470.68 $. Analysts predicted a price target of 546.03 $....


TSMJune 12, 2023TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED Hits Price Target with 20.28% Profit  ~1 min.

On January 18, 2023, QuantWave's forecast signal for TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED indicated a long position at a price of 85.89 $....